NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cassidy Bio

Cassidy Bio

Private
Tel AvivHealthcare & Life Scienceshttps://www.cassidybio.com/

Last Round

Seed

Nov 20, 2025

Total Funding Raised

$8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cassidy Bio is a biotechnology company developing an AI-driven genomic foundation model to enhance the design of gene editing therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

genomic foundation modelgene editing designin silico validationAI drug discoveryCRISPR designbase editinggenetic medicinebio-foundryAI biotechpredictive biologytherapeutic candidatewet-lab integrationcomputational biologydrug development platformbio-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cassidy Bio Comps

Public and private peers based on sector, stage, and business model.

Cassidy Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cassidy Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 20, 2025

Key People

Founding team and executive leadership

Yaniv Shmueli

CTO Co-Founder

Founding Team

Rom Kshuk

Co-Founder And CEO

Founding Team

Cassidy Bio Investors

Notable investors and investment history

Cassidy Bio investors
InvestorRounds
Lool VenturesSeed
Merck KGaASeed
Ahren Innovation CapitalSeed
10DSeed
AION LabsPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2026

    Monthly visitors increased 124% MoM.

Cassidy Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cassidy Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cassidy Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range17
Year Founded2024
Last FundingNov 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.